Cargando…

Real-World Long-Term Clinical Outcomes of Ultrathin Strut Biodegradable Polymer Drug-Eluting Stents in Korean ST-Segment-Elevation Myocardial Infarction (STEMI) Patients with or without Acute Heart Failure Undergoing Primary Percutaneous Coronary Intervention

Biodegradable polymers (BDPs) and ultrathin struts were recently introduced to drug-eluting stents (DES) to further improve outcomes. In this study, we analyzed and compared the effect of the ultrathin strut BDP-DES (UBDP-DES) with the conventional durable polymer-DES (DP-DES) in patients with ST-se...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jang, Albert Youngwoo, Yu, Jongwook, Oh, Pyung Chun, Kim, Minsu, Suh, Soon Yong, Lee, Kyounghoon, Han, Seung Hwan, Kang, Woong Chol
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8708844/ https://www.ncbi.nlm.nih.gov/pubmed/34945194 http://dx.doi.org/10.3390/jcm10245898

Ejemplares similares

Safety and Efficacy of Post-Dilation in Percutaneous Coronary Intervention Using Polymer-Free Ultrathin Strut Sirolimus-Probucol Coated Drug-Eluting Stents
por: Shin, Yonghoon, et al.
Publicado: (2023)

Comparison of 7-Year, Real-World Clinical Outcomes between Drug-Coated Balloon Angioplasty versus Drug-Eluting Stent Implantation in Patients with Drug-Eluting Stent In-Stent Restenosis
por: Kim, Minsu, et al.
Publicado: (2023)

The efficacy and safety of drug-eluting balloons for the treatment of in-stent restenosis as compared with drug-eluting stents and with conventional balloon angioplasty
por: Oh, Pyung Chun, et al.
Publicado: (2016)

Ultrathin Strut Biodegradable Polymer Sirolimus‐Eluting Stent Versus Durable‐Polymer Everolimus‐Eluting Stent for Percutaneous Coronary Revascularization: 2‐Year Results of the BIOSCIENCE Trial
por: Zbinden, Rainer, et al.
Publicado: (2016)

Ultrathin-strut biodegradable polymer versus durable polymer drug-eluting stents: a meta-analysis
por: Monjur, Mohammad Riashad, et al.
Publicado: (2020)

Clinical outcomes of ultrathin strut biodegradable polymer-coated everolimus-eluting stent in patients with coronary artery disease
por: Patted, Suresh V., et al.
Publicado: (2020)

Ultrathin Struts Drug-Eluting Stents: A State-of-the-Art Review
por: Leone, Attilio, et al.
Publicado: (2022)

Is There an Advantage of Ultrathin-Strut Drug-Eluting Stents over Second- and Third-Generation Drug-Eluting Stents?
por: Gherasie, Flavius-Alexandru, et al.
Publicado: (2023)

Arterial Healing 10 Months After Implantation of an Ultrathin-Strut, Biodegradable-Polymer, Sirolimus-Eluting Stent　― An Angioscopic Study ―
por: Tsujimura, Takuya, et al.
Publicado: (2021)

Safety and efficacy of ultrathin strut biodegradable polymer sirolimus-eluting stent versus durable polymer drug-eluting stents: a meta-analysis of randomized trials
por: Zhu, Ping, et al.
Publicado: (2018)

Improved early risk stratification of patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention using a combination of serum soluble ST2 and NT-proBNP
por: Yu, Jongwook, et al.
Publicado: (2017)

The Outcome of Ultrathin-Strut Biodegradable Polymer-Coated Sirolimus-Eluting Stents in Coronary Artery Disease Patients – A Feasibility Study
por: Panduranga, Prashanth, et al.
Publicado: (2023)

Prospective evaluation of an ultrathin strut biodegradable polymer-coated sirolimus-eluting stent: 12 months’ results from the S-FLEX UK registry
por: Choudhury, Anirban, et al.
Publicado: (2019)

Ultrathin Strut Biodegradable Polymer-Coated Sirolimus-Eluting Coronary Stents: Patient-Level Pooled Analysis From Two Indian Registries
por: Babu Pothineni, Ramesh, et al.
Publicado: (2023)

Outcome of percutaneous coronary intervention using ultrathin-strut biodegradable polymer sirolimus-eluting versus thin-strut durable polymer zotarolimus-eluting stents in patients with comorbid peripheral arterial disease: a post-hoc analysis from two randomized trials
por: Pinxterhuis, Tineke H., et al.
Publicado: (2023)

Elastic stent recoil in coronary total occlusions: Comparison of durable‐polymer zotarolimus eluting stent and ultrathin strut bioabsorbable‐polymer sirolimus eluting stent
por: Improta, Riccardo, et al.
Publicado: (2021)

Clinical outcomes of an ultrathin-strut sirolimus-eluting stent in all-comers population: Thailand Orsiro registry
por: Suwannasom, Pannipa, et al.
Publicado: (2021)

Real-World Use Of Ultrathin-Strut Biodegradable Polymer–Coated Sirolimus-Eluting Stents In Patients With Coronary Artery Disease: 6-Month Clinical Outcomes
por: Ajmera, Prakash, et al.
Publicado: (2019)

Thin Strut CoCr Biodegradable Polymer Biolimus A9-Eluting Stents versus Thicker Strut Stainless Steel Biodegradable Polymer Biolimus A9-Eluting Stents: Two-Year Clinical Outcomes
por: Menown, Ian B. A., et al.
Publicado: (2021)

Biodegradable polymer-coated thin strut sirolimus-eluting stent versus durable polymer-coated everolimus-eluting stent in the diabetic population
por: Gasior, Pawel, et al.
Publicado: (2021)

Faster smooth muscle cell coverage in ultrathin-strut drug-eluting stent leads to earlier re-endothelialization
por: Hahn, Dongwoo, et al.
Publicado: (2023)

Safety and Efficacy of a New Ultrathin Sirolimus-Eluting Stent with Abluminal Biodegradable Polymer in Real-World Practice
por: Youn, Young Jin, et al.
Publicado: (2019)

Diagnostic and prognostic role of nitroglycerin-induced dilation in patients with suspected vasospastic angina, combined with ergonovine provocation test
por: Kim, Minsu, et al.
Publicado: (2021)

Real-World Treatment Selection Factors and 7-Year Clinical Outcomes between Percutaneous Coronary Intervention and Coronary Artery Bypass Graft Surgery in Left Main Disease
por: Jang, Albert Youngwoo, et al.
Publicado: (2022)

Complete Versus Culprit-Only Revascularization for ST-Segment Elevation Myocardial Infarction and Multivessel Disease in the 2(nd) Generation Drug-Eluting Stent Era: Data from the INTERSTELLAR Registry
por: Kwon, Sung Woo, et al.
Publicado: (2018)

Gender-Associated Outcomes Following Percutaneous Coronary Intervention With a Third-Generation, Ultrathin-Strut Drug-Eluting Stent: A Real-World, Single-Center Experience
por: Gili, Sebastiano, et al.
Publicado: (2022)

High Bleeding Risk Patients Treated with Very Thin-Strut Biodegradable Polymer or Thin-Strut Durable Polymer Drug-Eluting Stents in the BIO-RESORT Trial
por: Zocca, Paolo, et al.
Publicado: (2018)

Impact of Statin Treatment on Strut Coverage after Drug-Eluting Stent Implantation
por: Suh, Yongsung, et al.
Publicado: (2015)

Safety and efficacy of biodegradable polymer-coated thin strut sirolimus-eluting stent vs. durable polymer-coated everolimus-eluting stent in patients with acute myocardial infarction
por: Gąsior, Paweł, et al.
Publicado: (2018)

Flexibility of Biodegradable Polymer Stents with Different Strut Geometries
por: Chen, Chong, et al.
Publicado: (2020)

Longitudinal Stent-Strut Injury at the Distal End of a Newer-generation Drug-eluting Stent
por: Jin, Uram, et al.
Publicado: (2017)

Pulsatile Compression of Stent-Graft by Re-pressurizing Aneurysmal Sac With Type III Endoleak After Endovascular Aneurysm Repair: A Case Report
por: Oh, Pyung Chun, et al.
Publicado: (2022)

Clinical Outcomes of World’s Thinnest (50 μmr) Strut Biodegradable Polymer Coated Everolimus-Eluting Coronary Stent System in Real-World Patients
por: Patted, Suresh V., et al.
Publicado: (2018)

3-Year Clinical Outcomes of Ultrathin Biodegradable Polymer-Coated Sirolimus-Eluting Stents: T-Flex Registry With High-Risk Subgroups
por: Pothineni, Ramesh Babu, et al.
Publicado: (2022)

Prognostic impact of alkaline phosphatase measured at time of presentation in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction
por: Oh, Pyung Chun, et al.
Publicado: (2017)

Biodegradable Cable-Tie Rapamycin-eluting Stents
por: Lee, Cheng-Hung, et al.
Publicado: (2017)

Efficacy and Safety of Polymer-Free Ultrathin Strut Sirolimus-Probucol Coated Drug-Eluting Stents for Chronic Total Occlusions: Insights from the Coroflex ISAR 2000 Worldwide Registry
por: Mahmood Zuhdi, Ahmad Syadi, et al.
Publicado: (2018)

Safety of 3‐Month Dual Antiplatelet Therapy After Implantation of Ultrathin Sirolimus‐Eluting Stents With Biodegradable Polymer (Orsiro): Results From the SMART‐CHOICE Trial
por: Yun, Kyeong Ho, et al.
Publicado: (2020)

A Comparison of Two Brands of Clopidogrel in Patients With Drug-Eluting Stent Implantation
por: Park, Yae Min, et al.
Publicado: (2012)

One-year performance of thin-strut cobalt chromium sirolimus-eluting stent versus thicker strut stainless steel biolimus-eluting coronary stent: a propensity-matched analysis of two international all-comers registries
por: Vlieger, Selina, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_s5b0ckb5elmf889ii65cfosemr